Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inova Schar Cancer Institute (ISCI) is a premier cancer care and research center located in Northern Virginia and is a key component of the Inova Health System. The institute offers a comprehensive, multidisciplinary approach to oncology, providing advanced treatments such as proton therapy, immunotherapy, and personalized medicine based on genomic profiling. ISCI is recognized for its patient-centric model, which integrates world-class clinical care with extensive support services through its "Life with Cancer" program. As a significant research hub, the institute conducts a wide array of clinical trials, including a robust Phase I program that provides patients with access to novel and investigational therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inova Cancer Center.